Cytokine-adjuvanted HIV-DNA vaccination strategies.

Franco Lori, David B Weiner, Sandra A Calarota, Laurene M Kelly, Julianna Lisziewicz
{"title":"Cytokine-adjuvanted HIV-DNA vaccination strategies.","authors":"Franco Lori,&nbsp;David B Weiner,&nbsp;Sandra A Calarota,&nbsp;Laurene M Kelly,&nbsp;Julianna Lisziewicz","doi":"10.1007/s00281-006-0047-y","DOIUrl":null,"url":null,"abstract":"<p><p>This review highlights some of the most common cytokines currently being tested as adjuvants in HIV-1-DNA vaccine regimens. We discuss their use in both the prophylactic and therapeutic setting. Finally, we describe a novel dendritic cell-targeted vaccine candidate for HIV-1 treatment and prevention called DermaVir and explore the combination of the DermaVir technology with the cytokine adjuvants interleukin-7 and interleukin-15.</p>","PeriodicalId":74860,"journal":{"name":"Springer seminars in immunopathology","volume":"28 3","pages":"231-8"},"PeriodicalIF":0.0000,"publicationDate":"2006-11-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://sci-hub-pdf.com/10.1007/s00281-006-0047-y","citationCount":"31","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Springer seminars in immunopathology","FirstCategoryId":"1085","ListUrlMain":"https://doi.org/10.1007/s00281-006-0047-y","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"","JCRName":"","Score":null,"Total":0}
引用次数: 31

Abstract

This review highlights some of the most common cytokines currently being tested as adjuvants in HIV-1-DNA vaccine regimens. We discuss their use in both the prophylactic and therapeutic setting. Finally, we describe a novel dendritic cell-targeted vaccine candidate for HIV-1 treatment and prevention called DermaVir and explore the combination of the DermaVir technology with the cytokine adjuvants interleukin-7 and interleukin-15.

细胞因子佐剂的HIV-DNA疫苗接种策略
这篇综述强调了目前在HIV-1-DNA疫苗方案中作为佐剂进行测试的一些最常见的细胞因子。我们讨论了它们在预防和治疗两方面的应用。最后,我们描述了一种用于治疗和预防HIV-1的新型树突状细胞靶向疫苗候选物DermaVir,并探索了DermaVir技术与细胞因子佐剂白介素-7和白介素-15的结合。
本文章由计算机程序翻译,如有差异,请以英文原文为准。
求助全文
约1分钟内获得全文 求助全文
来源期刊
自引率
0.00%
发文量
0
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
确定
请完成安全验证×
copy
已复制链接
快去分享给好友吧!
我知道了
右上角分享
点击右上角分享
0
联系我们:info@booksci.cn Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。 Copyright © 2023 布克学术 All rights reserved.
京ICP备2023020795号-1
ghs 京公网安备 11010802042870号
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术官方微信